PT-141 (Bremelanotide)
Published · Researched 2026-09-21
Category: Libido, Tanning, Sleep & Niche · Research date: 2026-09-20 · Slug: pt-141-bremelanotide
Overview
PT-141 is the research code name for bremelanotide, a synthetic cyclic heptapeptide melanocortin-receptor agonist (α-MSH analogue). It was developed from the Melanotan II research program at the University of Arizona / Palatin Technologies as a metabolite with reduced pigmentary activity and selectivity shifted toward central MC4R receptors. It is the active ingredient of Vyleesi, the FDA-approved prescription auto-injector for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women (approved June 2019). In 2026, the grey market sells it as 10 mg lyophilized vials from US and international research-peptide vendors, plus nasal-spray formulations sold by compounding/telehealth outfits (e.g., AgelessRx via sponsored creator partnerships). It is one of the most-discussed libido peptides online and functions centrally on desire/arousal rather than blood flow, unlike PDE5 drugs.
Social standing
Threads: Moderate but steady presence. @nootbro's "peptide cheatsheet" post (2026-06-22) lists "PT-141 = sex" and pulled 77 likes / 11 reposts — the shorthand that dominates peptide-culture naming. @privintel (TheBioArchitect, 2026-07-03) discussed PT-141 alongside kisspeptin for female HSDD after GLP-1/weight-loss, a framing echoed across women's health threads. A Malay-language thread (@adzatuty) asked simply "who here has used PT-141, does it work?" — the evergreen newcomer question.
Facebook: Facebook group chatter is the liveliest layer. A July 2026 post by certified trainer and peptide coach Thomas G. Sterner in the Over50BodybuildingFitness group (27 likes, 27 comments) warned men to "start with a low dose" and spawned the richest community dosing discussion observed: members reported personal use ranging 0.5–4 mg per injection, flushing described as "turns me as red as a lobster," stomach upset, and at least one non-responder at 2 mg. The coach added a notable claim that five grey-market China-sourced products he tested came back 40–60% stronger than labeled — unverified, but widely echoed distrust of anonymous imports. The same thread saw a recurring community claim that nasal-spray PT-141 "doesn't work" (countered by prescription nasal-spray users elsewhere).
Instagram: The most visible platform. Multiple physician/creator explainers in 2026:
- Dr. Joshua Gonzalez MD (@joshuagonzalezmd, 120K followers; FB reel 2026-05-20, 170K-follower page) framed PT-141 as brain-acting vs Viagra's blood-flow action, advised as-needed use max 2–3×/week, never daily; comments immediately pivoted to sourcing ("Where do you get PT 141? China. $6"), with one commenter citing FDA labeling to argue Vyleesi is not indicated for men.
- @debrito.dafne (nutrition/fitness coach, 120K followers; IG reel 2026-06-11) gave a negative personal testimonial — "rough nausea" at below-label doses, no effect for her — while commenters split between "Orgasm in a bottle. Works great for men and women" and reports of flushing/nausea. The comment section was heavily spammed with copy-paste promotion of spartanlab.shop (vendor spam, not organic).
- Dr. Kristi Sawicki PhD (@drkristi.sawicki, 46K followers; IG reel 2026-09-07) reported "pretty remarkable" personal results from an AgelessRx nasal spray — flagged SPONSORED (#ad, 30% off code DRKRISTI30), so treat as brand content, not independent evidence.
- Dr. Diego Allende DO (@doctorallende, 12K; reel 2026-09-15) listed mole darkening, flushing, nausea, and priapism risk.
- Dr. Alfredo Hoyos (verified plastic surgeon, 1.4M followers) warned about arterial hypertension and cardiovascular stress and against combining with stimulants/recreational drugs.
- Dr. Rena Malik MD (verified urologist) podcast clip (2026-08-23) cautioned against melanotan 2 while noting PT-141 is prescribed clinically "with regularity."
Recurring praise: acts on desire itself rather than mechanics; works for both sexes; fast onset (community reports ~30–60 min); some users describe strong, reliable effect ("Orgasm in a bottle").
Recurring complaints: nausea (the #1 complaint — rough enough to make some quit), flushing/face redness, headache, fatigue, blood-pressure increases; inconsistent response (some feel nothing at 2 mg); poor batch consistency from grey-market vendors; nasal sprays viewed skeptically by injectable-using community members.
Social validation
Tier: Tier 1 — independent evidence across all three: Facebook group discussion, Instagram owner/creator content, and Threads mentions, plus physician-authored explainers.
Named sources and what each proves:
- Facebook group "Over50BodybuildingFitness" (Thomas G. Sterner thread, 2026-07-15) — proves active community dosing culture (0.5–4 mg), side-effect consensus (flushing, nausea), and distrust of China grey-market quality.
- Instagram @debrito.dafne (2026-06-11) — proves the negative-experience side exists (nausea intolerability, non-response) and documents comment spam as a vendor-manipulation vector (spartanlab.shop).
- Instagram @joshuagonzalezmd / Dr. Joshua Gonzalez (2026-05-20) — proves physician-level dosing guidance circulating socially (as-needed, ≤2–3×/week) and community price-sourcing debates.
- Threads @nootbro (2026-06-22) and @privintel (2026-07-03) — prove PT-141's shorthand status ("PT-141 = sex") and its pairing with kisspeptin in women's libido discussions.
- Instagram @drkristi.sawicki (2026-09-07) — proves prescription nasal-spray channel exists (AgelessRx) but is SPONSORED; kept separate from organic evidence.
Key specs table
| Spec | Detail |
|---|---|
| Identity | Bremelanotide (PT-141), cyclic heptapeptide α-MSH analogue |
| Sequence | Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys-OH) |
| Formula / MW | C50H68N14O10 · 1025.2 g/mol · CAS 189691-06-3 |
| Target | Melanocortin receptors, MC4R-selective (central) |
| Vial sizes (grey market) | 10 mg lyophilized per vial (standard); nasal-spray formulations via telehealth/compounding |
| Half-life | ~2.7 h SC (range ~1.9–4.0 h); Tmax ~1 h; ~100% SC bioavailability; 21% protein-bound; 64.8% urine / 22.8% feces (FDA clinical pharmacology review data for the approved product) |
| Community-reported research use | 0.5–2 mg per use most commonly cited in groups; label dose (Vyleesi) 1.75 mg SC ≥45 min before activity, ≤1 dose/24 h, ≤8 doses/month. Community-reported only — not instructions. |
| Storage | Lyophilized: −20 °C long-term (vendors also state RT stable ~90 days); reconstituted: 2–8 °C, use within ~30 days; avoid freeze–thaw |
Pricing
All prices observed 2026-09-20 from research-peptide vendor listings (grey market, research-use-only). All 10 mg vials unless noted.
| Vendor | Price (10 mg vial) | Notes |
|---|---|---|
| Blue Sky Peptide | $30.22 (list $54.95) | cheapest observed |
| Peptide Pros | $37.50 (list $59.99) | bulk tiers to 20% off |
| Polaris Peptides | $40.00 | |
| PurePharma.ph | $40.00 | |
| Ameano Peptides | $44.00 | |
| Optimum Formula | $27.99/vial at 10+ | bulk-only low price |
| PeptideDeck → Ascension Peptides | $49.00 ($24.50 w/ listed code) | code advertised on page, checkout price not independently verified |
- Street range: ~$30–$50 per 10 mg vial at single-vial pricing.
- Branded Vyleesi auto-injector (prescription): ~$900 for four 1.75 mg doses cited on vendor page — UNVERIFIED, could not confirm current 2026 pharmacy pricing.
- Facebook Marketplace: no listings observed for PT-141 (search returned empty, 2026-09-20) — used-value range UNVERIFIED.
- Community anecdote in social comments: "$6" China sourcing mentioned by a commenter — UNVERIFIED and flagged by other commenters as a quality risk.
What's included / what's needed
Vial listings ship the lyophilized 10 mg vial only (some vendors add a per-lot COA). Community members report needing separately: bacteriostatic water (vendors explicitly sell it alongside — Peptide Pros prompts "Don't Forget the Sterile Water"), insulin syringes for subcutaneous use. Reconstitution commonly discussed as 2 mL bacteriostatic water → 5 mg/mL stock (community-reported framing, not a recommendation). Nasal-spray users via telehealth (AgelessRx) receive a finished prescription spray — distinct from research vials.
Support reality
No manufacturer warranty exists on research vials; several vendors advertise satisfaction guarantees (e.g., Peptide Pros claims replacement "if you are not fully satisfied") — these are vendor policies, not enforceable warranties, and community reports on honoring them are mixed. Parts/service: N/A — there is no service channel; COAs are the only quality instrument, and the community's standing advice is to demand per-lot third-party COAs. Vendor reputation is entirely word-of-mouth in groups; no independent certification body exists. Ad-heavy vendors (spartanlab.shop spam in comment sections) show weak organic interest relative to their spam volume — treat spam-driven visibility as negative signal.
Community verdict
PT-141 is the most socially validated libido peptide in this track: physician explainers, owner testimonials, and Facebook group dosing threads all agree it acts on desire centrally and can work well — but the nausea/flushing tax is real and widely reported, with roughly the FDA trial profile (nausea ~40%, flushing ~20%) echoed in community anecdotes. Quality inconsistency from grey-market vials is the dominant trust complaint; the branded Vyleesi path is acknowledged but priced ~10–20× higher per use.
Regulatory & safety status
- FDA-approved drug exists: bremelanotide as Vyleesi, approved June 21, 2019, for acquired, generalized HSDD in premenopausal women only. Dose: 1.75 mg SC auto-injector, ≥45 min before activity, max 1 dose/24 h and 8 doses/month. NOT indicated for men, postmenopausal women, or performance enhancement (per FDA label, DailyMed 03/2024). Contraindicated in uncontrolled hypertension and known cardiovascular disease; raises BP ~6/3 mmHg transiently.
- Research vials sold online are NOT FDA-approved for human use — they are unapproved research chemicals carrying "research use only" labels. The 2019 approval does not transfer to them.
- EMA: no EU approval for bremelanotide identified — UNVERIFIED whether any member-state authorization exists; assume not approved in EU.
- Common adverse events (Vyleesi trials): nausea 40%, flushing 20%, injection-site reactions 13%, headache 11%, vomiting 4.8%. Rare: priapism (erections >4 h) reported; community threads echo prolonged/unwanted erection anecdotes, especially combined with PDE5 drugs.
Image views
6 of 8 views obtained (vendor product images, JPEG). Note: the peptide grey market's standard product imagery is vendor-rendered vial mockups — all six images are the actual vendor listing images, not AI-generated by this project. The "scale" and "real-owner-in-use" views were unavailable; no social owner photos of PT-141 vials could be verified as real (IG content was reels/testimonials, not product photos).
- hero:
img/pt-141-bremelanotide-hero.jpg(Ascension/PeptideDeck 10 mg vial) - side-profile:
img/pt-141-bremelanotide-side-profile.jpg(Ameano Peptides 10 mg vial) - rear:
img/pt-141-bremelanotide-rear.jpg(OmegaPeps studio vial shot) - top-angle:
img/pt-141-bremelanotide-top-angle.jpg(AR Labs vial) - detail:
img/pt-141-bremelanotide-detail.jpg(Peptides World 10 mg label close view) - box-accessories:
img/pt-141-bremelanotide-box-accessories.jpg(Performance Clinics branded vial) - scale: unavailable — no vendor image with a size reference found (ironmountainlabz, platinumresearchcompounds blocked/failed; alternatives exhausted)
- real-owner-in-use: unavailable — no verifiable real-owner product photos found
Not medical advice. This is research documentation only. PT-141/bremelanotide research vials are not approved for human use; Vyleesi is a prescription drug for a narrow indication. Consult a licensed healthcare provider.
Named sources
- Facebook group "Over50BodybuildingFitness" (Thomas G. Sterner thread, 2026-07-15) — proves active community dosing culture (0.5–4 mg), side-effect consensus (flushing, nausea), and distrust of China grey-market quality. (2026-07-15)
- Instagram @debrito.dafne (2026-06-11) — proves the negative-experience side exists (nausea intolerability, non-response) and documents comment spam as a vendor-manipulation vector (spartanlab.shop). (2026-06-11)
- Instagram @joshuagonzalezmd / Dr. Joshua Gonzalez (2026-05-20) — proves physician-level dosing guidance circulating socially (as-needed, ≤2–3×/week) and community price-sourcing debates. (2026-05-20)
- Threads @nootbro (2026-06-22) and @privintel (2026-07-03) — prove PT-141's shorthand status ("PT-141 = sex") and its pairing with kisspeptin in women's libido discussions. (2026-06-22)
- Instagram @drkristi.sawicki (2026-09-07) — proves prescription nasal-spray channel exists (AgelessRx) but is SPONSORED (2026-09-07)
- @adzatuty — A Malay-language thread (@adzatuty) asked simply "who here has used PT-141, does it work?" — the evergreen newcomer question.
- @doctorallende — Diego Allende DO** (@doctorallende, 12K; reel 2026-09-15) listed mole darkening, flushing, nausea, and priapism risk. (2026-09-15)
Source URLs were not recorded for these references.